We’re excited to be part of #SCDMChina this year, taking place from 3 - 4 July in Shanghai. Visit booth \#6 tomorrow to meet our team and learn how ICON is revolutionising clinical research with cutting-edge data-driven ...
Global regulatory strategies for immunology
Success factors for hypercompetitive therapy
Read the whitepaperFrom here to where?
Plotting a course to bring APAC-developed drugs to the world
Read the whitepaperFrom innovation to implementation: Navigating neurologic monoclonal antibody development
Read the whitepaperMaking sense of the rapidly changing biosimilars landscape
Strategies for adapting and achieving optimal market access
Read the whitepaper
Featured solutions
Orbis
ICON’s multi-agent platform that connects human expertise, data and AI across the clinical trial lifecycle.
EngageAI
Our voice of the customer feedback platform has been enhanced using AI; transforming how we listen, respond, and act on your feedback.
Blended solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Outcome Measures
A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Cardiac Safety Solutions
End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
Early Clinical and Bioanalytical Solutions
Innovative early clinical solutions that will advance your drug development strategy.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
Market Access
Expertise in mission-critical pricing, market access, and reimbursement.
Specialty Laboratory Solutions
Supporting precision medicine programs across all phases of drug diagnostic co-development.
Videos
ICON overview
ICON is expanding the possibilities of clinical research for customers, partners, and patients.
Biotech
Developing transformative therapies with small & mid-sized biopharma companies requires a flexible approach.
PV
regulatory intelligence
Stay compliant throughout any local or global regulatory change.
AI @ICON
ICON is harnessing AI with pragmatic, impactful, award winning solutions for a healthier world.
Oncology
Explore how ICON supports oncology development with faster start‑up and predictable delivery.
